Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Optical Coherence Tomography More Cost-Effective Than Fluorescein Angiogram in Diagnosing Macular Di
Link ID 5279
Title Optical Coherence Tomography More Cost-Effective Than Fluorescein Angiogram in Diagnosing Macular Di
Url http://www.medscape.com/viewarticle/573655?src=rss
Description Introducing optical coherence tomography can improve the quality of patient care while saving money. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Apr 30, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Once-Daily Fluvoxamine Approved for Treatment of SAD and OCD
  The FDA has approved a once-daily extended-release formulation of fluvoxamine maleate for the treatment of social anxiety disorder and obsessive-compulsive disorder. Medscape Medical News
Category:   Articles > Business of Medicine


2. Educating the Health Professional for Improving Cultural Competency
  An expert panel discusses three areas of cultural competence--bias, language barriers, and communication--in the context of clinician-patient vignettes. Medscape Internal Medicine
Category:   Articles > Business of Medicine


3. Panel to Recommend FDA Oversight of Genetic Testing
  In advance of its formal April report, an advisory committee is calling for closing gaps in oversight of clinical validity through a Web-based registry of genetic and other laboratory tests, among other strategies. Medscape Medical News
Category:   Articles > Business of Medicine


4. FDA Approves Test for Hepatitis B Viral Load
  The US Food and Drug Administration has approved the first nucleic acid test for hepatitis B virus that measures blood levels of viral DNA as an estimate of viral load. Medscape Medical News
Category:   Articles > Business of Medicine


5. Abbott Labs and Solvay Sued in 18 States for Monopoly Efforts With TriCor
  Abbott and two units of Solvay SA are accused of undermining efforts to bring generic drugs to market by patenting new formulations of TriCor with only minor changes to the drug. Heartwire
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS